Analytical Data
-
Gene name
DEFB106A
- Application
-
Alternative Names
DEFB106A；BD6；DEFB106；DEFB6；Beta-defensin 106
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N104
-
Expression Region
21-65aa
-
AA Sequence
FFDEKCNKLK GTCKNNCGKN EELIALCQKS LKCCRTIQPC GSIID
-
Molecular Weight
7.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Akirin1 is a crucial protein that plays a significant role in various biological processes, including immunity, development, and stress response in organisms. Research into Akirin1 has gained momentum due to its involvement in critical pathways such as the NF-κB signaling pathway, which is essential for regulating immune responses and inflammation. Understanding the structure and function of recombinant Akirin1 can provide insights into its mechanisms of action and its potential therapeutic applications. Studies have shown that Akirin1 can interact with various transcription factors, influencing gene expression and modulating signaling pathways. Furthermore, its role in muscle development and regeneration has made it a subject of interest in regenerative medicine and muscle-related diseases. Researchers are exploring the potential of recombinant Akirin1 in various applications, including gene therapy and biotechnology, as well as its implications in understanding disease mechanisms in conditions like cancer and autoimmune disorders. Overall, the investigation of Akirin1 and its recombinant forms is vital for elucidating the complex interactions within cellular signaling networks and for advancing potential therapeutic strategies.
